Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2014, Article ID 563243, 4 pages
http://dx.doi.org/10.1155/2014/563243
Clinical Study

Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate

1Department of Obstetrics and Gynecology, University of Florida College of Medicine, 1600 SW Archer Road, P.O. Box 100294, Gainesville, FL 32610-0294, USA
2University of Tennessee Health Science Center, Memphis, TN 38163, USA
3Department of Clinical Research, Alere, Women’s & Children’s Health, Atlanta, GA 30339, USA

Received 30 May 2014; Revised 22 September 2014; Accepted 2 October 2014; Published 27 October 2014

Academic Editor: Eric Doucet

Copyright © 2014 Robert Egerman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Tracy A. Manuck, “17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?,” Seminars in Perinatology, 2017. View at Publisher · View at Google Scholar
  • Klara Rosta, Johannes Ott, Fanni Kelemen, Wilhelm Temsch, Tobias Lahner, Theresa Reischer, Hanns Helmer, and Aniko Somogyi, “Is vaginal progesterone treatment associated with the development of gestational diabetes? A retrospective case–control study,” Archives of Gynecology and Obstetrics, 2018. View at Publisher · View at Google Scholar
  • Hee Joong Lee, Errol Norwitz, and Banghyun Lee, “Relationship between threatened miscarriage and gestational diabetes mellitus,” BMC Pregnancy and Childbirth, vol. 18, no. 1, 2018. View at Publisher · View at Google Scholar
  • Fernand D. Samson, Danielle L. Tate, Luis M. Gomez, Amanda L. Merriman, and Katherine Apostolakis-Kyrus, “Adjuvant administration of 17-α-hydroxy-progesterone caproate in women with three or more second trimester pregnancy losses undergoing cervical cerclage is no more effective than cerclage alone,” Journal of Perinatal Medicine, vol. 46, no. 2, pp. 155–161, 2018. View at Publisher · View at Google Scholar
  • Ahizechukwu C. Eke, Jeanne Sheffield, and Ernest M. Graham, “17α-Hydroxyprogesterone Caproate and the Risk of Glucose Intolerance in Pregnancy,” Obstetrics & Gynecology, vol. 133, no. 3, pp. 468–475, 2019. View at Publisher · View at Google Scholar
  • R. V. Kapustin, O. N. Arzhanova, and O. N. Bespalova, “Exogenous progesterone as a factor for the development of gestational diabetes mellitus,” Rossiiskii vestnik akushera-ginekologa, vol. 19, no. 1, pp. 38, 2019. View at Publisher · View at Google Scholar